
Patanjali Foods Clarifies FDA Action on Cow Ghee Stock
Patanjali Foods Ltd has issued a clarification regarding an action initiated by the Food and Drug Administration (FDA), Maharashtra, concerning certain stock of Patanjali Cow Ghee held by a super distributor/Food Business Operator (FBO). The company states that the FDA communication was not addressed to Patanjali Foods directly but to the FBO. Samples were collected for testing, but as of the disclosure date, no authenticated laboratory test reports confirming failure of quality parameters have been received by the company or the FBO. Directions have been issued regarding the identified stock, including a restriction on sale pending further action. Patanjali Foods reiterates its commitment to quality and compliance, is seeking details, and will cooperate with authorities. The company believes conclusions should await authenticated laboratory findings and will make further disclosures as material developments occur.
Key Highlights
- FDA action concerns stock held by a distributor, not directly addressed to Patanjali Foods.
- No authenticated laboratory reports confirming product failure have been received.
- Company reiterates commitment to quality and regulatory compliance.
- Patanjali Foods is cooperating with authorities and seeking further details.
- Further disclosures will be made upon receipt of material developments.
Price Impact
More from PATANJALI